|External Advisory Board|
Within the framework of SCR&Tox an independent Advisory Board was set up with representatives of the big pharmaceutical and cosmetic industry, members of regulatory bodies interested in toxicology, as well as an ethical advisor.
Members of the Advisory Board
Dr. Laura Suter-Dick holds a Ph D in biology and has long term experience in Pharmaceutical Industry. After working as a Ph D-student at Schering AG (Berlin), Laura joined the toxicology department at Sandoz (now Novartis) as a post-doc and then moved to F. Hoffmann-La Roche, Ltd. in 1996. She specialized during her PhD in reproductive biology and then gained experience in the field of toxicology, with a strong focus on molecular toxicology and toxicogenomics. During the last 10 years or so, Laura specialized in mechanistic toxicology; she and her colleagues developed and implemented toxicogenomics and other new technologies, with the main focus on elucidating and predicting toxicity. Currently, she acts as a Senior Scientific Advisor in the Early & Investigative Safety department at F. Hoffmann-La Roche, Ltd., dealing with in vitro assays, mechanistic investigations, and immunosaftey. Her main scientific interest lies on new technologies and their application for the mechanistic understanding of cell biology and toxicology.